Marizomib has been used as a proteasome inhibitor:to study its effects on glioblastoma cell linesto analyze its effects on the aging of killifish brainto test its effect on protein kinase B (PKB/AKT) levels in multiple myeloma cells
Biochem/physiol Actions
Marizomib a natural product is a marine-derived ?-lactone-?-lactam. It shows therapeutic effects against hematologic and solid tumor malignancies.. It is involved in the activation of caspase-3,-8, and -9, increases the reactive oxygen species (ROS) and promotes apoptosis. Marizomib can cross the blood-brain barrier and might have the potential to treat primary brain tumors. It possesses anti-tumor properties.
Marizomib is a second generation proteasome inhibitor with anti-cancer activity. Marizomib binds irreversibly and potently inhibits all three 20S proteasome subunits.